Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Poolbeg Pharma Ltd. ( (GB:POLB) ) has shared an update.
Poolbeg Pharma PLC has announced a change in major holdings, with Michael Kelly increasing his stake in the company. Kelly now holds 7.09% of the voting rights, up from a previous 6.18%. This change reflects a significant shift in the company’s shareholder structure, potentially impacting its governance and strategic decision-making going forward.
More about Poolbeg Pharma Ltd.
YTD Price Performance: -30.99%
Average Trading Volume: 2,079,128
Technical Sentiment Consensus Rating: Buy
For detailed information about POLB stock, go to TipRanks’ Stock Analysis page.